Heath Lukatch has an estimated net worth of $3.78 Million. This is based on reported shares across multiple companies, which include Vaxcyte, Inc., Flexion Therapeutics Inc, Inogen Inc, and Satsuma Pharmaceuticals, Inc..

2018 was Heath Lukatch's most active year for acquiring shares with 8 total transactions. Heath Lukatch's most active month to acquire stocks was the month of May. 2018 was Heath Lukatch's most active year for disposing of shares, totalling 25 transactions. Heath Lukatch's most active month to dispose stocks was the month of October. 2017 saw Heath Lukatch paying a total of $604,940.00 for 39,332 shares, this is the most they've acquired in one year. In 2017 Heath Lukatch cashed out on 28,000 shares for a total of $1,356,239.73, their largest year based on trade value.